Different Approaches to Potentiate the Immune Response Induced by a 12-Mer Synthetic Peptide

Current Protein and Peptide Science

Volumn 1, Issue 2, 2000, Pages 125-137

  Haro, I ^a   Gomara M J ^a  

^a DEPARTMENT OF ENVIRONMENTAL CHEMISTRY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A VIRUS;

ANTIGEN; CAPSID PROTEIN; EPITOPE; HYBRID PROTEIN; LIPOSOME; PEPTIDE FRAGMENT; SUBUNIT VACCINE; VIRUS ANTIBODY; VP3 PEPTIDE (110 121), HEPATITIS A VIRUS; VP3 PEPTIDE (110-121), HEPATITIS A VIRUS;

AMINO ACID SEQUENCE; ARTICLE; B LYMPHOCYTE; BIOSYNTHESIS; CHEMISTRY; GENETICS; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; PROTEIN CONFORMATION; SYNTHESIS; T LYMPHOCYTE; VIRUS CAPSID;

AMINO ACID SEQUENCE; ANTIBODIES, VIRAL; ANTIGENS; B-LYMPHOCYTES; CAPSID; CAPSID PROTEINS; EPITOPES; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; HEPATITIS A; HEPATITIS A VIRUS; HUMANS; LIPOSOMES; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES; VACCINES, SUBUNIT;

EID: 0346742537     PISSN: 13892037     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389203003381388     Document Type: Article

References (79)

1. Koff, R.S. (1998) Lancet, 341, 1643-49.
2. Lewis, J.A. (1999) Hepatitis A vaccines, In: Viral Hepatitis: Diagnosis, Therapy & Prevention, (Specter, S., Ed.), Humana Press Inc, Totowa, NJ.
3. Meloen, R.H., Casal, J.I., Dalsgaard, K. and Langeveld, J.P.M. (1995) Vaccine, 13 (10), 885-886.
4. Milich D.R. (1989) Adv. Immunol., 45, 195-264.
5. Steward M.W. and Howard C.R. (1987) Immunol. Today, 8, 51-57.
6. Borras-Cuesta F., Petit-Camurdan A. and Fedan Y. (1987) Eur. J. Immunol., 17, 1213, 1216.
7. Russo, S., Turin, L., Zanella, A., Ponti, W. and Poli, G. (1997) Medical Research Reviews, 17 (3), 277-301.
8. Van Regenmortel, M.H.V. (1993) Annales de Biologie Clinique, 51, 39-41.
9. Bosch, A., González-Dankaart, J.F., Haro, I., Gajardo, R., Pérez, J.A. and Pintó, R.M. (1998) J. Med. Virol., 54, 95-102.
10. Hopp, J.P. and Woods, K.R. (1981) Proc. Natl., Acad. Sci. USA, 78, 3824-3828.
11. Ruoslahti, E. and Pierschbacher, M.D. (1987) Science, 238, 491-497.
12. Fox, G., Parry, N.R., Barnett, P.V., McGinn, B,. Rowlands, D.J. and Brown, F. (1989) J. Gen. Virol., 70, 625-637.
13. Pérez, J.A., González-Dankaart, J.F., Reig, F., Pintó, R.M., Bosch, A. and Haro, I. (1995) Biomed. Pept. Protein & Nucleic Acids, 1, 93-100.
14. Pérez, J.A., Cantó, J., Reig, F., Pérez, J.J. and Haro, I. (1998) Biopolymers, 45, 479-492.
15. Mestres, C., Pérez, J.A., Reig, F., Haro, I. and Alsina, M.A. (1997) Colloid Polym. Sci., 275, 946-952.
16. Pérez, J.A., Haro, I., Martín, I., Alsina, M.A. and Reig, F. (1995) Anal. Chim. Acta, 303, 65-72.
17. Chávez, A., Busquets, M.A., Pujol, M., Alsina, M.A. and Cajal, Y. (1998) Analyst, 123, 2251-2256.
18. Sospedra, P., Alsina, M.A., Haro, I., Mestres, C. and Busquets, M.A. (1999) J. Colloid Interface Sci., 211, 130-136.
19. Chávez, A., Pujol, M., Haro, I., Alsina, M.A. and Cajal, Y. (1999) Langmuir, 15, 1101-1107.
20. Pérez, J.J., Sharkey, M. and Centeno, N.B. (1996) J. Biomol. Struct. Dynam., 14, 185-191.
21. Marshall, G.R. (1992) Curr. Opin. Struct. Biol., 2, 904-919.
22. Blumenstein, M., Matsueda, G.R., Timmons, S. and Hawiger, J. (1992) Biochemistry, 31, 10692-10698.
23. Zvi, A., Hiller, R. and Anglister, J. (1992) Biochemistry, 31, 6972-6979.
24. Wooley, G. A. and Deber, C.M. (1987) Biopolymers, 26, 109-121.
25. Ono, S., Lee, S., Mihara, H., Aoyagi, H., Kato, T. and Yamasaki, N. (1990) Biochim. Biophys. Acta, 1022, 237-244.
26. Luo, M., Rossman, M.G. and Palmenberg, A.C. (1988) Virology, 166, 503.
27. Cantó, J., Pérez, J.A., Centeno N.B., Haro, I. and Pérez, J.J. (1997) Letters in Peptide Science, 4, 13-19.
28. Zegers, N.D., Van Holten, C., Claassen, E. and Boersma, W.J.A. (1993) in Peptides 1992, (Schneider, C.H. and Eberle, A.N., Eds.), p.932, ESCOM Science Publishers B.V., Leiden, Netherlands.
29. Isaguliants, M.G., Koshida, R., Ruden, U. and Wahren, B. (1996) Biochemistry, 61 (7), 872-877.
30. Isaguliants, R., Ruden, U. and Wahren, B. (1996) Biochemistry, 61 (7), 878-885.
31. Ivanov, V.S., Kulik, L.N., Gabrilian, A.E., Tchikin, L.D., Kozhich, A.T. and Ivanov, V.T. (1994) FEBS Lett., 345, 159.
32. García, M., Pujol, M., Reig, F., Alsina, M.A. and Haro, I. (1996), Analyst, 121, 1583-1588.
33. Partidos, C., Standley, C. and Steward, M. (1992) Eur. J. Immunol. 22, 2675-2680.
34. Partidos, C., Standley, C. and Steward, M. (1992) Mol. Immunol., 29 (5), 651-658.
35. Sarobe, P., Lasarte, J.J., Larrea, E., Golvano, J.J., Prieto, I., Gullón, A., Prieto, J. and Borrás-Cuesta, F. (1993), Res. Immunol., 144, 257-262.
36. Denton, G., Hudecz, F., Kajtár, J., Murray, A., Tendler, S.J.B. and Price, M.R. (1994) Peptide Res., 7 (5), 258-264.
37. Partidos, C. and Kanse, C. (1997) Mol. Immunol., 34 (16-17), 1105-1111.
38. Maillere, B. and Herve, M. (1997) Mol. Immunol., 34 (14), 1003-1009.
39. Lelievre, D., Hsu, S-C, Daubos, P., Favard, C., Vigny, P., Trudelle, Y., Steward, M.W. and Delmas, A. (1997) Eur. J. Biochem., 249, 895-904.
40. Rajadhyaksha, M. and Thanavala, Y. (1995) Proc. Natl. Acad. Sci. USA, 92, 1575-1579.
41. Thanavala, Y. (1996) J. Biotechnol., 44, 67-73.
42. Gómara M.J., Girona V., Reig F., Alsina M.A. and Haro I. (1999) Materials Science and Engineering C, 8-9, 487-493.
43. Gómara, M.J., Girona, V., Reig, F., Alsina, M.A., Haro, I., (1999) Biomed. Chromatogr., 13, 167-168.
44. Kersten, G.F.A. and Crommelin, D.J.A. (1995) Biochim. Biophys. Acta, 1241, 117-138.
45. Galvain, S., André, C., Vatrinet, C. and Villet, B. (1999) Curr. Ther. Res., 60 (5), 278-294.
46. Freda Pietrobon P.J. (1995) in Vaccine Design: The Subunit and Adjuvant Approach, (Powell M.F. and Newman M.J., Eds.), Plenum Press, New York.
47. Dal Monte, P. and Szoka, F.C. (1989) J. Immunol., 142, 1437-1443.
48. Therien H.M., Shahum E. and Fortin A. (1991) Cell Immunol., 136, 402-413.
49. Reig, F., Alsina, M.A., Busquets, M.A., Valencia, G. and García-Antón, J.M. (1989) J. Microencapsul., 6, 277.
50. Haro, I., Bosch, A. and Reig, F. (1994) Current Topics in Peptide & Prot. Res., 1, 135-149.
51. Rouaix, F., Gras-Masse, H., Mazingue, C., Diesis, E., Ridel, P.R., Estaquier, J., Capron, A., Tartar, A. and Auriault, C. (1994) Vaccine, 12 (13), 1209-1214.
52. Deprez, B., Sauzet, J-P., Boutillon, C., Martinon, F., Tartar, A., Sergheraert, C., Guillet, J-G., Gomard, E. and Gras-Masse, H. (1996) Vaccine, 14 (5), 375-382.
53. Boeckler, C., Frisch, B., Muller, S. and Schuber, F. (1996) J. Immunol. Methods, 191, 1-10.
54. Friede, M., Muller, S., Briand, J.P., Van Regenmortel, M.H.V. and Schuber, F. (1993) Mol. Immunol., 30, 539.
55. Vea, A., Gómara, M.J., Reig, F. and Haro, I. (1998) In Innovation and Perspectives in Solid Phase Synthesis & Combinatorial Libraries, (Epton, R., Ed.), pp. 401-404, Mayflower Sci. Ltd., Kingswinford, U.K.
56. García, M., Alsina, M.A., Reig, F. and Haro, I. (2000) Vaccine, 18, 276-283.
57. Mota, F.M., Busquets, M.A., Reig, F., Alsina, M.A. and Haro, I. (1996) J. Coll. Interface Sci., 188, 81-93.
58. Muñoz, G., García, M., Reig, F., Alsina, M.A. and Haro, I. (1998) Analyst, 123, 2223-2228.
59. Sela, M. (1980) in Molecules, cells and parasites in immunology, (Larralde, C., Wills, K., Ortiz-Ortiz, L. and Sela, M., Eds.), pp. 215-228, Academic Press, NY.
60. Hudecz, F. (1995) Biomed. Pep. Protein Nucleic Acids, 1, 213-220.
61. García, M., Nagy, I.B., Alsina, M.A., Mezo, G., Reig, F., Hudecz, F. and Haro, I. (1998) Langmuir, 14, 1861-1869.
62. Sospedra, P., Nagy, I.B., Haro, I., Mestres, C., Hudecz, F. and Reig, F. (1999) Langmuir, 15 (15), 5111-5117.
63. Hudecz, F. (1995) Anti-cancer Drugs, 6, 171-193.
64. Tsikaris, V., Sakarellos, C., Sakarellos-Daitsiotis, M., Orlewski, P., Marraud, M., Thong Cung, M., Vatzaki, E. and Tzartos, S. (1996) Intl. J. Biol. Macromol., 19, 195-205.
65. Tam J.P. (1996) J. Immunol. Methods, 196, 17-32.
66. Briand J-P., Barin C. Van Regenmortel M.H.V. and Muller S. (1992), J. Immunol. Methods. 156, 255-265.
67. Veprek, P. And Jezek, J. (1999) J. Peptide Sci., 5, 5-23.
68. Nardin, E.H., Oliveira, G.A., Calvo-Calle, J.M. and Nussenzweig, R.S. (1995), Adv. Immunol., 60, 105-149.
69. Alsina, A., Pérez, J.A., García, M., Reig, F. and Haro, I. (1997) Supramolecular Science, 4, 195-199.
70. Firsova, T.V., Perez, J.A., Reig, F., Kniglov, I.V. and Haro, I. (1998) in Peptides 1996, (Ramage, R. and Epton, R., Eds.), pp. 383-384, Mayflower Sci. Ltd., Kingswinford, U.K.
71. Pinto, R.M:, Gonzalez-Dankaart, J.F., Sanchez, G., Guix, S., Gomara, M.J., García, M., Haro, I. and Bosch, A. (1998) FEBS Letters, 438, 106-110.
72. Reynolds, S.R., Dahl, C.E. and Harn, D.A. (1994) J. Immunol., 152, 193-200.
73. Tam, J.P., Clavijo, P., Lu, Y., Nussenzweig, V., Nussenzweig, R. and Zavala, F. (1990) J. Exp. Med., 171, 299-306.
74. Ahlborg, N., Nardin, E.H., Perlmann, P., Berzins, K. and Andersson, R. (1998) Vaccine, 16 (1), 38-44.
75. Gupta, R.K. and Siber, G.R. (1995) Vaccine, 13 (14), 1263-1276.
76. Goodman-Snitkoff, G., Eisele, L.E., Heimer, E.P., Felix, A.M., Andersen, T.T., Fuerst, T.R. and Mannino, R.J. (1990) Vaccine, 8, 257-262.
77. Sanchez, Y., Ionescu-Matiu, I., Dreesman, G.R., Kramp, W., Six, H.R., Holliger, F.B. and Melnick, J.L. (1980) Infect. Immun., 30, 728-733.
78. Gomara, M.J., Riedemann, S., Vega, I., Ibarra, H., Ercilla, G. and Haro, I. (2000) J. Immunol. Methods, 234, 23-34.
79. Tam J.P. and Zavala F. (1989) J. Immunol. Methods, 124, 53-61.